Patent · US Active

Pyrrolopyrimidine compound

US10561657B2 · kind B2 · utility

1Cited by

0References

19Claims

0Family size

Assignees

Inventors

Li Zhu · Shanghai, CN
Dengming Xiao · Longmont, US
Yuandong Hu · Beijing, CN
Liguang Dai · Beijing, CN
Xiaowei Duan · Beijing, CN
Yinghui Sun · Beijing, CN
Yong Peng · Beijing, CN
Fansheng Kong · Beijing, CN
Hong Luo · Clemson, US
Yongxin Han · Kirkland, CA
Ling Yang · Lianyungang, CN
Shanchun Wang · 安丰镇, CN

Key dates

Filing date	Dec 15, 2015
Grant date	Feb 18, 2020
Priority date	—
Expiry date	Jul 7, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to the field of pharmaceutical chemistry, and in particular, to a pyrrolopyrimidine compound represented by general formula (I), a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The present invention further relates to a method for preparing the pyrrolopyrimidine compound represented by general formula (I), pharmaceutical compositions and an application of the pyrrolopyrimidine compound in treating diseases mediated by Janus Kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.